Marimastat
| CAS No. | 154039-60-8 | Cat. No. | BCP10998 |
| Name | Marimastat | ||
| Synonyms | BB 2516;BB2516;BB-2516;GI 5712;GI5712;GI-5712;KB-R 8898;TA 2516; TA2516; TA-2516; | ||
| Formula | C15H29N3O5 | M. Wt | 331.41 |
| Description | Marimastat, aslo known as BB-2516 and TA-2516, is an orally-active synthetic hydroxamate and inhibitor of matrix metalloproteinases with potential antineoplastic activity. Marimastat covalently binds to the zinc(II) ion in the active site of matrix metalloproteinases (MMPs), thereby inhibiting the action of MMPs, inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. This agent may also inhibit tumor necrosis factor-alpha converting enzyme (TACE), an enzyme involved in tumor necrosis factor alpha (TNF-alpha) production that may play a role in some malignancies as well as in the development of arthritis and sepsis. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | MMP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.